Statute Consultation open for Full (pharma) Members: April 2015
Dear Full Members
Last year the Executive Board took a hard look at the Association’s Statutes and realised that they were no longer aligned with our Strategic Plan and did not reflect the way the Association works in today’s industry.
A Working Party was appointed to overhaul the Statutes:
- James Rienow, Pfizer and former Board member
- Michel Bruguiere Fontenille, Treasurer
- Bernadette Rogers, General Manager
….….and a series of telecons took place to discuss the direction the Statutes should take and how to bring them up to date and as future proof as possible. The Executive Board was also consulted on key points and important changes. The result is this document which in the left hand column shows the current statutes and the right shows the proposed new text. Sections have been streamlined and duplication erased, terminology updated and additions made to future proof the Statutes so as to avoid having to regularly ‘tweak’ the Statutes.
So the Executive Board would now like to invite pharma members to review the proposed new Statutes and provide any input prior to finalisation and then voting. Such a major change warrants this period of consultation. You can either send your comments by email or comment in this document and email it back to email@example.com
Deadline for comments is 12 May.
Many thanks, Executive Board
The proposed new Statutes compared to the current statutes can be found
The current Statutes of the Association can be found in full in this pdf document: